Confusion over shifting Centers for Disease Control and Prevention COVID-19 vaccine recommendations are reigniting questions ...

The strong immune response was confirmed in CHIKV-naïve children with a 96.5% seroresponse rate (full dose) at Day 180. VLA1553 was well tolerated in children aged one to eleven years regardless of ...

The CDC’s restricted communication under HHS oversight has hindered public awareness amid rising global disease outbreaks ...

Chikungunya, a mosquito-borne virus, has been detected at higher-than-expected rates among U.S. travelers from the Indian state. To reduce infection risk, the CDC urges travelers to adopt mosquito ...